NCT01260727: Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults |
|
|
| Completed | 1 | 92 | US, RoW | PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine, Placebo MVA-CMDR Vaccine | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections | 12/13 | 06/15 | | |
